*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
John McDonad, Ph.D. - faculty organizer
Summary Sentence: "Targeting Protein-protein Interactions for New Cancer Therapeutics" - Shaomeng Wang, Ph.D. - University of Michigan
Full Summary: No summary paragraph submitted.
Integrated Cancer Research Center"Targeting Protein-protein Interactions for New Cancer Therapeutics"
Shaomeng Wang, Ph.D.
Warner-Lambert/Parke-Davis Professor in Medicine
Professor of Medicine
Pharmacology and Medicinal Chemistry
Director, Michiha Center for Therapeutics Innovation
University of Michigan
Biography
Shaomeng Wang, Ph.D., obtained his B.S. degree from Peking University and his Ph.D. degree from Case Western Reserve University. His postdoctoral training was at National Institutes of Health. He is currently the Warner-Lambert/Parke-Davis Professor in Medicine at Michigan and Editor-in-Chief of Journal of Medicinal Chemistry. Dr. Wang has published 260 peer-reviewed papers, is an inventor of 40 issued patents. Dr. Wang has co-founded several biotech companies and has advanced 6 novel anticacner drugs into clinical development. Dr. Wang won the 2014 University of Michigan Distinguished Innovator Award and was elected as a fellow of the National Academy of Inventors (U.S.A.).
Integrated Cancer Research Center (ICRC)
Georgia Tech has been a leader in the development of collaborative approaches to both cancer diagnostics and therapeutics. The mission of the Integrated Cancer Research Center is to facilitate integration of the diversity of technological, computational, scientific and medical expertise at Georgia Tech and partner institutions in a coordinated effort to develop improved cancer diagnostics and therapeutics.
